Idexx Laboratories (IDXX) Non-Current Debt (2009 - 2026)

Idexx Laboratories' Non-Current Debt history runs 18 years deep, the most recent figure standing at $299.9 million for Q1 2026.

• In Q1 2026, Non-Current Debt fell 33.34% year-over-year to $299.9 million; the TTM figure through Mar 2026 stood at $299.9 million (down 33.34% YoY), while the FY2025 annual figure was $374.8 million, down 16.66% from the prior year.
• Non-Current Debt was $299.9 million for Q1 2026 at Idexx Laboratories, down from $374.8 million in the prior quarter.
• In the past five years, Non-Current Debt ranged from a high of $773.4 million in Q1 2022 to a low of $299.9 million in Q1 2026.
• Historically, Non-Current Debt has averaged $570.6 million across 5 years, with a median of $618.8 million in 2023.
• The sharpest annual moves came in 2022 and 2026: Non-Current Debt fell 0.69% in 2022, then slumped 33.34% in 2026.
• A 5-year view of Non-Current Debt shows it stood at $694.4 million in 2022, then decreased by 10.3% to $622.9 million in 2023, then slipped by 27.79% to $449.8 million in 2024, then dropped by 16.66% to $374.8 million in 2025, then retreated by 20.01% to $299.9 million in 2026.
• The last three Non-Current Debt figures came in at $299.9 million (Q1 2026), $374.8 million (Q4 2025), and $374.8 million (Q3 2025), per Business Quant data.